The FDA approved Zepbound based on the SURMOUNT clinical trial program , which enrolled over 5,000 participants across multiple phase 3 studies
Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
supporting fatty liver within the context of an associated metabolic problem
Kennedy Jr., a former independent candidate in the 2024 presidential election, has pledged to "Make America Healthy Again" borrowing from Trump's campaign slogan, "Make America Great Again" (MAGA)
This network connects the ventral tegmental area (VTA) to the nucleus accumbens and is responsible for the hit of pleasure you feel when eating something delicious, receiving good news, or critically consuming alcohol or other addictive substances
Changes in Detoxification Your liver will still detoxify your body, but it might not work as efficiently without the extra glutathione boost